Cannabidiol (CBD) is a beneficial cannabis compound with several health benefits. CBD vapes are products constituting cannabidiol, VG, and PG. They are specifically designed for vaping. CBD oil drops have carrier oils formulated for sublingual or oral consumption. Learn more differences in this blog.
The cannabis industry dominates the market with its incredible products. They come in a wide range, such as cannabidiol (CBD) vapes, oils, tinctures, and edibles. Outright mistruths, exaggeration, and misinformation surround cannabis products following their close similarity. Individuals administer CBD through various consumption methods. Cannabidiol vapes are products formulated specifically for vaping. Cannabis lovers reap CBD benefits by inhaling vape juice through vaping devices. However, some consider cannabidiol oil drops. Here, the product is administered by placing these drops beneath the tongue. This enables cannabinoids to absorb into the bloodstream to yield results. Read more to understand the differences between vapes and sublingual CBD oil drops.
Are CBD Vapes And CBD Oil Drops the Same?
Allem et al. (2019) noted that cannabidiol vapes are also called vape juice or E-liquids. They are specifically manufactured for vaping. CBD vapes comprise Vegetable glycerine (VG), propylene glycol (PG), and cannabidiol. PG is health friendly and non-toxic for human intake. Also, lacks flavor, thus better at distinguishing terpenes or flavors used often. Cannabidiol is an active cannabis compound in vapes. It contains multiple benefits without causing intoxicating effects. For example, the anti-oxidative and anti-inflammatory properties are essential in boosting body health and wellness. Unlike CBD, tetrahydrocannabinol (THC) generates euphoric and psychoactive effects. They cause highness in enthusiasts who prioritize marijuana-derived products. VG is the fundamental producer of billows exhaled when vaping. It is clear though thinner with higher synthetically and throat hit made. Cannabidiol oil drops are designed explicitly for sublingual consumption. This product is extracted from cannabis plants. Most reputable manufacturers obtain CBD oil from the hemp plant, a cannabidiol-dense cannabis strain. Carbon dioxide is passed over plant materials in supercritical temperatures. Here, CBD is extracted from them. The extract undergoes winterization to separate CBD from chlorophyll, terpenes, and waste materials. This extract has high consistency making its usage difficult. Manufacturers incorporate a base oil like coconut, jojoba, and medium chain triglycerides (MCT) olive oil. The supercritical carbon dioxide extraction technique is prioritized. This is because it does not leave harmful solvent materials on the final product. Sometimes essential oils are incorporated to boost the flavor.
CBD Vapes Vs. CBD Oils
C:\Users\ADMIN\AppData\Local\Temp\Temp2_786.zip\based_vaping_products_and_supplement_formulations_reported_by_consumers_to_precipitate_adverse_effectsHolt et al. (2022) showed that both vape liquids and cannabidiol oils are derived from hemp plants. Generally, trademarks utilize industrial hemp containing a 0.3% THC threshold. Hemp-derived cannabidiol is not federally authorized. However, most States can tolerate it since it does not cause psychoactive and euphoric effects. US States that uphold the MMJ program allows consumers to trade marijuana-derived cannabidiol for recreational and medicinal purposes. Though the two products come from marijuana or hemp botanicals, they constitute diverse constituents. Cannabidiol oil has base oil, terpenes, and natural flavorings formulated for oral or sublingual consumption. Although cannabidiol vape liquid contains base oils, its consistency is lower than CBD oil. Such is important since the carriers utilized in cannabidiol oil, including olive or coconut oil, have high consistency. This becomes difficult for vaping devices to vaporize it. Normally, manufacturers incorporate thinning compounds like VG and PG for more effective vaping.
Pros and Cons of Both Sublingual Cannabidiol Oil and Vaping
Vaping Has Higher Bioavailability
Bioavailability is determined by the cannabidiol amount that enters the human bloodstream. Tukova et al. (2009) added that the CBD oil bioavailability range between 25-40 percent. Contrastively, vaping offers approximately 50-60 percent bioavailability, though certain researchers propose even 80 percent. Vaping allows cannabinoids to pass through the lungs and enter the bloodstream. This provides faster results and allows more products to penetrate the bloodstream. However, the sublingual intake method involves placing some cannabidiol oil drops beneath the tongue. The product is held there for about 60 seconds for cannabinoids to absorb into the body through mucous membranes. The capillaries beneath the tongue convey the product directly to the bloodstream. You can wash off or swallow the remainder under the tongue. Comparing the two, you require less cannabidiol to achieve the anticipated effects when vaping than sublingually. In this regard, it becomes less expensive than its counterpart.
Vaping Has More Convenience
Glasser et al. (2020) revealed that vaping is the most convenient among the CBD consumption methods. This means that when taking cannabidiol, you switch on the device. Heat the vaping juice or oil to an appropriate temperature. Finally, you inhale through the device to allow therapeutic cannabinoids to absorb into the bloodstream. This is more convenient than measuring the dose using droppers and placing the product beneath the tongue.
Dosing Sublingual CBD Oils Is Easier
When dosing cannabidiol oil, the consumer considers the following:
The product amount in the container
The CBD amount in the product per milliliter
The cannabidiol oil amount a dropper can carry.
Users can determine the dose depending on their body weight. This creates an opportunity to adjust the dropper volume to equal the dose guidelines. However, it is difficult to determine dosage when vaping. This is because you cannot calculate precisely the amount consumed by counting the number of hits. But most brands offer procedures for cannabidiol vaping devices. They indicate the CBD amount in one waft. For example, if one waft constitutes 2.25 milligrams of cannabidiol, the consumers should inhale 4 times to achieve their daily dose.
Vaping Has Faster Onset Results
Cannabidiol oil is absorbed sublingually first before entering the bloodstream. Sublingual consumption method yield results faster than edible formulations like gummies and capsules. Nonetheless, it would help if you waited fifteen to thirty minutes to begin enjoying the cannabidiol health benefits. In contrast, vaping allows cannabidiol to enter the bloodstream directly from the lungs to yield faster results.
Cannabidiol products have incredible benefits and are taken through different consumption methods. CBD vapes are products designed specifically for vaping. In contrast, cannabidiol oil is designed for oral or sublingual consumption. Manufacturers incorporate carrier oils when extracting this product. This helps to reduce consistency and make it palatable. Besides carrier oil, reputable brands incorporate thinning agents when making CBD vapes. This lowers thickness to make the end product vapeable. This product has higher bioavailability, quicker results onset, and is more convenient than its counterpart. Therefore, consider this product if seeking such advantages. However, consider CBD oil when finding a product easier to dose.
Allem, Majmundar, Dharmapuri, Cruz, & Unger (2019). E-Liquid-Related Posts To Twitter In 2018: Thematic Analysis. Addictive Behaviors Reports, 10, 100196.
Glasser, Macisco, Miller, Garbsch, Wermert, & Nemeth (2020). Smoking Cessation Methods Among Homeless Youth In A Midwestern City. Addictive Behaviors Reports, 11, 100276.
Holt, Karin, Butler, Ferreira, Krotulski, Poklis, & Peace (2022). Cannabinoid‐Based Vaping Products And Supplement Formulations Reported By Consumers To Precipitate Adverse Effects. Drug Testing And Analysis.
Tukova, Chladek, Nemcova, Chladkova, & Dolezalova (2009). Methotrexate Bioavailability After Oral And Subcutaneous Administration In Children With Juvenile Idiopathic Arthritis. Clin Exp Rheumatol, 27(6), 1047-1053.